News

Interview with Stewart Cole

an interview with Stewart Cole
Dr. Stewart Cole

Stewart Cole helped create the Global Health Institute in 2007. Located at the Ecole polytechnique fédérale de Lausanne (EPFL), will use cutting-edge techniques to seek solutions to tuberculosis, a growing threat worldwide. Dr Cole’s work on tuberculosis, leprosy, AIDS, gas gangrene and bacterial molecular genetics is widely acclaimed throughout the world. He was a leading member of the team of scientists who determined the complete nucleotide sequence for the AIDS virus. He is also considered to be a pioneer in the genomics of tuberculosis and leprosy bacilli.

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...